TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
TB-Speed Pneumonia
Conditions: Tuberculosis; Severe Pneumonia Intervention: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
Community-based Tuberculosis Tracing and Preventive Therapy
Condition: Tuberculosis Intervention: Other: Screening and initiating preventive therapy in communities Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Epicentre; University of Sheffield; Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
Condition: Multi-drug Resistant Tuberculosis Intervention: Drug: 18-month regimen containing 6 anti-TB drugs Sponsor: Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2019 Category: Research Source Type: clinical trials
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine for Treatment of Patients With MDR-TB
Condition: Tuberculosis, Multidrug-Resistant Interventions: Drug: Delamanid; Drug: Levofloxacin; Drug: Bedaquiline; Drug: Clofazimine; Drug: Linezolid; Combination Product: WHO approved MDR-TB treatment regimens Sponsors: Boston University; United States Department of Defense; Novartis Pharmaceuticals; Pfizer; Otsuka Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials
Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
Condition: Multi-drug Resistant Tuberculosis Intervention: Sponsors: University of Cape Town; Partners in Health; Harvard Medical School; Medicines Sans Frontieres Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2019 Category: Research Source Type: clinical trials
